Summary
Actym Therapeutics
Founded in 2017
Description
Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
Strengths
- Actym Therapeutics has a strong market share in their industry
- Since Actym Therapeutics was founded, the company has grown faster than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
Annual Revenue
Actym Therapeutics's annual revenue
$1366000
Based on Kona Equity data
-
Revenue per employee
$170750
-
Annual revenue growth since founding
$195142
Employee Count
8 employees
Executives
Bret Peterson
Scientist
b**@actymthera.comJames Stutz
Chief Business Officer
j**@actymthera.comHailey He
Associate Director, Process Development
h**@actymthera.comSheriese Rush
Head of Operations
s**@actymthera.comChan Whiting
Chief Development Officer
c**@actymthera.comKeith Cheung
Scientist II
k**@actymthera.comTawny Darling
Associate Director, Business Operations
t**@actymthera.comJulie Janes
Scientist I
j**@actymthera.comHaixing Kehoe
Scientist II
h**@actymthera.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
TRIGR Therapeutics , Inc.
trigrrx.com- Founded in 2018
- Location: Irvine, CA
- Annual Revenue: $9.2M
- Employees: 7
Veana Therapeutics
veana-therapeutics.com- Founded in 2012
- Location: Portland, OR
- Annual Revenue: $1.2M
- Employees: 5
- Developing Safer, More Efficient Cancer Immunotherapies
Aminex Therapeutics
aminextx.com- Founded in 2008
- Location: Kirkland, WA
- Annual Revenue: $1.3M
- Employees: 5
- Aminex Therapeutics, Inc., is a drug development company exclusively focused on development and clinical efficacy of a unique cancer immunotherapy drug in the general category of cancer immunomodulators.
BioEclipse Therapeutics
bioeclipse.com- Founded in 2017
- Location: South San Francisco, CA
- Annual Revenue: $5.8M
- Employees: 14
- BioEclipse Therapeutics is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics.
Amphivena Therapeutics Inc
amphivena.com- Founded in 2012
- Location: South San Francisco, CA
- Annual Revenue: $7.2M
- Employees: 20
Key Information
- Name: Actym Therapeutics
- Category: Biotechnology
- Industry: Biotechnology company
- SIC: 87; 873
- NAICS: 54; 541
See similar companies
-
By City Berkeley Small Biotechnology company in Berkeley Mid-size Biotechnology company in Berkeley Biotechnology in Berkeley Small Biotechnology in Berkeley Mid-size Biotechnology in Berkeley
-
By State CA Small companies in CA Biotechnology in CA Small Biotechnology in CA Mid-size Biotechnology in CA Small Biotechnology company in CA Mid-size Biotechnology company in CA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology company Small Biotechnology company Mid-size Biotechnology company Biotechnology and Biotechnology company
-
Firmographic data G Score of 2 Founded in 2017 SIC: 87 SIC: 873 NAICS: 54 NAICS: 541 #Business Services #Research & Development
Frequently Asked Questions
Actym Therapeutics's headquarters are located at 626 Bancroft Way Ste A Berkeley, CA 94710.
Actym Therapeutics's official website is actymthera.com
Actym Therapeutics's annual revenue is $1.4 M.
Actym Therapeutics's SIC: 87; 873
Actym Therapeutics's NAICS: 54; 541.
Actym Therapeutics has 8 employees
Actym Therapeutics is in the industry of Biotechnology.
